1. Home
  2. FHN vs BIO Comparison

FHN vs BIO Comparison

Compare FHN & BIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • FHN
  • BIO
  • Stock Information
  • Founded
  • FHN 1864
  • BIO 1952
  • Country
  • FHN United States
  • BIO United States
  • Employees
  • FHN N/A
  • BIO N/A
  • Industry
  • FHN Major Banks
  • BIO Biotechnology: Laboratory Analytical Instruments
  • Sector
  • FHN Finance
  • BIO Industrials
  • Exchange
  • FHN Nasdaq
  • BIO Nasdaq
  • Market Cap
  • FHN 11.0B
  • BIO 7.7B
  • IPO Year
  • FHN N/A
  • BIO N/A
  • Fundamental
  • Price
  • FHN $21.09
  • BIO $330.42
  • Analyst Decision
  • FHN Buy
  • BIO Strong Buy
  • Analyst Count
  • FHN 20
  • BIO 4
  • Target Price
  • FHN $24.10
  • BIO $333.50
  • AVG Volume (30 Days)
  • FHN 17.4M
  • BIO 226.4K
  • Earning Date
  • FHN 10-15-2025
  • BIO 10-29-2025
  • Dividend Yield
  • FHN 2.85%
  • BIO N/A
  • EPS Growth
  • FHN 19.36
  • BIO N/A
  • EPS
  • FHN 1.64
  • BIO 11.49
  • Revenue
  • FHN $3,185,000,000.00
  • BIO $2,554,200,000.00
  • Revenue This Year
  • FHN $12.50
  • BIO $2.05
  • Revenue Next Year
  • FHN $2.81
  • BIO $2.86
  • P/E Ratio
  • FHN $12.82
  • BIO $28.75
  • Revenue Growth
  • FHN 3.75
  • BIO N/A
  • 52 Week Low
  • FHN $15.19
  • BIO $211.43
  • 52 Week High
  • FHN $23.70
  • BIO $387.99
  • Technical
  • Relative Strength Index (RSI)
  • FHN 43.41
  • BIO 64.06
  • Support Level
  • FHN $20.54
  • BIO $326.64
  • Resistance Level
  • FHN $21.00
  • BIO $343.12
  • Average True Range (ATR)
  • FHN 0.81
  • BIO 10.09
  • MACD
  • FHN -0.07
  • BIO 2.26
  • Stochastic Oscillator
  • FHN 33.08
  • BIO 74.88

About FHN First Horizon Corporation

First Horizon Corp is the parent company of First Tennessee Bank, a prominent regional bank with about 200 branches around Tennessee. The company's reportable segments are: Commercial, Consumer & Wealth, Wholesale, and Corporate. The majority of its revenue is generated from Commercial, Consumer & Wealth. The Commercial, Consumer & Wealth segment offers financial products and services, including traditional lending and deposit taking, to commercial and consumer clients in the southern USA and other selected markets.

About BIO Bio-Rad Laboratories Inc.

Bio-Rad Laboratories, headquartered in Hercules, California, develops, manufactures, and sells products and solutions for the clinical diagnostics and life sciences markets. In clinical diagnostics (60% of sales), Bio-Rad sells test systems and specialized quality controls for clinical laboratories. In life sciences (40% of sales), it develops and manufactures instruments and reagents used in research, biopharmaceutical production, and food testing and has a leadership position in dPCR technology. The company is geographically diverse, with major markets in the Americas (about 40% of sales), Europe (about 30%), Asia (about 30%), and other. Bio-Rad owns approximately 33% of Sartorius, a lab and bioprocessing supplier that specializes in single-use technology used in biologics manufacturing.

Share on Social Networks: